Clinuvel Pharmaceuticals
CUV.AX
#7296
Rank
S$0.46 B
Marketcap
$9.26
Share price
-0.27%
Change (1 day)
-30.08%
Change (1 year)

EPS for Clinuvel Pharmaceuticals (CUV.AX)

EPS in 2023: $0.54

According to Clinuvel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.54. In 2023 the company made an earnings per share (EPS) of $0.54 an increase over its 2022 EPS that were of $0.38.

EPS history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023$0.5440.79%
2022$0.38-22.53%
2021$0.4961.74%
2020$0.31-12.03%
2019$0.3528.75%
2018$0.2779.08%
2017$0.15-318.99%
2016-$0.06877-71.6%
2015-$0.2436.75%
2014-$0.18-23.66%
2013-$0.23-45.84%
2012-$0.43-18.99%
2011-$0.5325.76%
2010-$0.42-22.24%
2009-$0.54-10.59%
2008-$0.6046.78%
2007-$0.41-34.2%
2006-$0.63-25.89%
2005-$0.8440.91%
2004-$0.6055.12%
2003-$0.3952.02%
2002-$0.2571.69%
2001-$0.15355.46%
2000-$0.03251